Online Therapy for Anxiety and Depression in Adults With Type 1 Diabetes
Tests online talk therapy with glucose monitor review in adults with type 1 diabetes.
Key facts
- Who runs it
- Albert Einstein College of Medicine
- Where
- Boston and The Bronx, United StatesSee the 2 sites
- Trial code
- Registry title
- Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
- Status
- Recruiting
- People taking part
- 94 people, planned
- Started
- 31 Mar 2023
- Expected to end
- Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Unified protocol for cognitive behavioral therapy (UP-CBT)
- Continuous Glucose Monitoring (CGM)
- Record updated
- 30 October 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 1 diabetes who also have an anxiety or depressive mood disorder. It tests therapy by video or phone plus review of continuous glucose monitor data.
- Age
- 18-64 years old
- Sex
- All sexes can join.
- Disease stage
- Type 1 diabetes for at least 6 months, and an anxiety or depressive mood disorder confirmed by a structured diagnostic interview.
- Earlier treatment
- People who had cognitive behavioral therapy (CBT) in the last year or plan to start it cannot join. If you recently started a psychotropic medicine, you must be on a stable dose for 6 weeks before joining.
Main reasons for not taking part
- Developmental or sensory disability that gets in the way of taking part
- Current pregnancy
- Bipolar disorder, psychotic disorder, severe eating disorder, severe substance abuse disorder, or acute suicide or self-harm risk
- Medicines or recent medical procedures that would affect blood sugar control or continuous glucose monitor (CGM) use during the study
- Cognitive behavioral therapy (CBT) in the last year or plans to start it
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Type 1 diabetes (T1D) duration ≥ 6 months
- 18-64 years old
- English- or Spanish-speaking
- Anxiety or depressive mood disorder as per structured diagnostic interview
Who cannot take part
- Received cognitive behavioral therapy (CBT) in last year or plans to initiate CBT; (6) temporary exclusion for recent initiation of psychotropic medication - must be on a stable dose for 6 weeks prior to enrollment
- Bipolar disorders, psychotic disorders, severe eating disorders, severe substance abuse disorders, or acute suicidal risk or self-harm
- Use of medications or recent medical procedures that would impact glycemic control or use of continuous glucose monitoring (CGM) over the study
- Developmental or sensory disability interfering with participation
- Current pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in United States
- Boston UniversityBoston, United StatesContact: Todd Farchione, PhDTaking people
- Albert Einstein College of MedicineThe Bronx, United StatesContact: Keyla Ordonez, BSTaking people
About the trial
What the trial wants to find out
This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.
The 2 groups in the trial
- Unified Protocol for Cognitive Behavioral Therapy (UP-CBT) with Continuous Glucose MonitoringTreatment being tested
Participants randomized to this arm will receive the Unified Protocol for Cognitive Behavioral Therapy (UP-CBT), enhanced by review of Continuous Glucose Monitoring (CGM) data. Participants will wear study-supplied CGM for the first 6 months of their participation in the trial.
Treatment: Unified protocol for cognitive behavioral therapy (UP-CBT) and Continuous Glucose Monitoring (CGM)
- Continuous Glucose Monitoring (CGM) OnlyExisting treatment, for comparison
Participants randomized to receive Continuous Glucose Monitoring (CGM) will continue to receive their usual care and will also wear CGM throughout the first 6 months of their participation in the trial.
Treatment: Continuous Glucose Monitoring (CGM)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults With Type 1 Diabetes
- Plain-language title
- Online Therapy for Anxiety and Depression in Adults With Type 1 DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05734313, who can take part
- Record updated
- 30 October 2025